Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Haoxiangni Health Food Co.,Ltd. (002582.SZ)

Compare
10.54
-0.46
(-4.18%)
At close: 3:04:09 PM GMT+8
Loading Chart for 002582.SZ
  • Previous Close 11.00
  • Open 10.90
  • Bid 10.53 x --
  • Ask 10.54 x --
  • Day's Range 10.48 - 11.03
  • 52 Week Range 4.28 - 12.62
  • Volume 43,478,391
  • Avg. Volume 75,935,573
  • Market Cap (intraday) 4.971B
  • Beta (5Y Monthly) 0.46
  • PE Ratio (TTM) --
  • EPS (TTM) -0.17
  • Earnings Date --
  • Forward Dividend & Yield 1.00 (9.09%)
  • Ex-Dividend Date Sep 4, 2024
  • 1y Target Est --

Haoxiangni Health Food Co.,Ltd. engages in the research, development, procurement, production, and sale of healthy foods in China. It offers red dates, nuts, dried fruits, and freeze-dried products. The company was formerly known as Haoxiangni Jujube Co., Ltd. and changed its name to Haoxiangni Health Food Co.,Ltd. in September 2017. Haoxiangni Health Food Co.,Ltd. was founded in 1992 and is headquartered in Xinzheng, China.

www.haoxiangni.cn

2,016

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 002582.SZ

View More

Performance Overview: 002582.SZ

Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002582.SZ
27.29%
SSE Composite Index (000001.SS)
2.24%

1-Year Return

002582.SZ
110.68%
SSE Composite Index (000001.SS)
6.59%

3-Year Return

002582.SZ
59.03%
SSE Composite Index (000001.SS)
2.54%

5-Year Return

002582.SZ
55.17%
SSE Composite Index (000001.SS)
15.44%

Compare To: 002582.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 002582.SZ

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    4.97B

  • Enterprise Value

    4.20B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.61

  • Price/Book (mrq)

    1.39

  • Enterprise Value/Revenue

    2.31

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.95%

  • Return on Assets (ttm)

    -1.25%

  • Return on Equity (ttm)

    -1.95%

  • Revenue (ttm)

    1.81B

  • Net Income Avi to Common (ttm)

    -71.76M

  • Diluted EPS (ttm)

    -0.17

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.56B

  • Total Debt/Equity (mrq)

    22.20%

  • Levered Free Cash Flow (ttm)

    146.39M

Research Analysis: 002582.SZ

View More

Company Insights: 002582.SZ

Research Reports: 002582.SZ

View More

People Also Watch